查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1555647

介入性肿瘤学市场：2024-2031年全球产业分析、规模、占有率、成长、趋势、预测

Interventional Oncology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 196 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球介入肿瘤学市场的详细报告。本报告对市场驱动因素、趋势、机会和挑战等关键市场动态进行了全面分析，提供了对市场结构的深入见解。

主要见解

  • 介入性肿瘤学市场规模（2024年）：21亿美元
  • 预测市场规模（2031年）：35亿美元
  • 全球市场成长率（2024-2031年年复合成长率）：8.1%

介入性肿瘤学市场：研究范围

介入性肿瘤学市场包括利用射频消融、冷冻消融和微波消融等先进技术进行癌症治疗的微创手术。这些技术目的是减少患者的不适和恢復时间，同时提供有效的肿瘤靶向，并推动医院、诊所和家庭健康环境对此类治疗的需求。癌症盛行率上升、影像技术进步以及对以患者为中心的护理的日益关注推动了市场成长。镇静、疼痛管理和监测技术的创新改善患者的整体治疗体验，进一步推动市场扩张。

推动市场成长的因素：

全球介入肿瘤学市场主要是由癌症盛行率的增加和微创治疗的日益采用所推动的。诊断影像和介入设备的技术进步提高手术的准确性和安全性，有助于改善患者的治疗结果。此外，随着患者和医疗保健提供者越来越喜欢恢復更快、併发症更少的侵入性较小的治疗方法，对标靶癌症治疗的需求上升。设备技术的创新和对个人化癌症治疗的日益重视也推动了市场成长，研发投资推动新技术的发展。

市场限制因素：

儘管介入肿瘤学市场成长前景广阔，但仍面临挑战，包括低收入和中等收入国家获得先进治疗的机会有限。医疗保健基础设施不足、专家短缺以及尖端设备成本高昂限制了资源贫乏地区对这些治疗方法的采用。此外，在获得现代介入肿瘤学技术方面的差异阻碍了患者的治疗效果，特别是在发展中国家。解决这些障碍需要世界各地大力改善医疗基础设施、培训和先进癌症治疗的可用性。

市场机会：

介入性肿瘤学市场存在巨大的商机，特别是随着对个人化医疗和家庭护理的需求不断成长。 MRI 和 CT 扫描等诊断影像工具的创新提高肿瘤靶向的准确性，并创造进一步的市场成长机会。电子商务平台和直接面向消费者的管道的扩展也使这些技术更容易获得，特别是在偏远地区。此外，与医疗保健提供者和健康中心的合作推动介入肿瘤设备的采用，进一步支持市场扩张。

本报告涵盖的主要问题

  • 推动介入性肿瘤学市场全球成长的关键因素是什么？
  • 哪些产品类型在市场上成长最快，例如消融设备？
  • 影像技术和病患监测的进步如何影响介入性肿瘤学市场的竞争格局？
  • 谁是介入肿瘤学市场的主要参与者？他们保持竞争力的策略是什么？
  • 介入性肿瘤市场的新趋势和未来前景是什么？

目录

第1章 执行摘要

第2章 市场概述

  • 市场范围与定义
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 课题
    • 主要趋势
  • 宏观经济因素
    • 世界产业展望
    • 世界 GDP 成长前景
    • 全球医疗保健支出前景
  • 新冠肺炎（COVID-19）影响分析
  • 预测因子 - 相关性和影响

第3章 增值见解

  • 监理状况
  • 产品采用率分析
  • 价值链分析
  • 主要交易和合併
  • PESTLE分析
  • 波特五力分析

第4章 全球介入性肿瘤学市场展望：过去（2019-2023年）与预测（2024-2031年）

  • 主要亮点
    • 市场规模（十亿美元）和年成长率
    • 绝对的获利机会
  • 市场规模分析与预测（十亿美元）
    • 2019-2023年市场规模（十亿美元）分析
    • 2023-2031年市场规模（十亿美元）分析与预测
  • 全球介入性肿瘤学市场展望：产品
    • 简介/主要调查结果
    • 2019-2023年市场规模（十亿美元）分析
    • 2024-2031年市场规模（十亿美元）分析与预测
      • 放射治疗设备
      • 消融装置
        • 微波消融
        • 射频消融术
        • 冷冻疗法
        • 其他
      • 栓塞装置
        • 微导管
        • 导丝
  • 市场吸引力分析：产品
  • 全球介入性肿瘤学市场展望：癌症类型
    • 简介/主要调查结果
    • 2019-2023年市场规模（十亿美元）分析
    • 2024-2031年市场规模（十亿美元）分析与预测
      • 肺癌
      • 肝癌
      • 肾癌
      • 其他
  • 市场吸引力分析：癌症类型
  • 全球介入肿瘤学市场展望：最终用户
    • 简介/主要调查结果
    • 2019-2023年市场规模（十亿美元）分析
    • 2024-2031年市场规模（十亿美元）分析与预测
      • 医院
      • 专科诊所
      • 门诊手术中心
      • 其他
  • 市场吸引力分析：最终用户

第5章 全球介入性肿瘤学市场展望：地区

  • 主要亮点
  • 2019-2023年市场规模（十亿美元）分析
  • 2024-2031年市场规模（十亿美元）分析与预测
    • 北美
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东、非洲
  • 市场吸引力分析：地区

第6章 北美介入性肿瘤学市场展望：过去（2019-2023年）与预测（2024-2031年）

第7章 欧洲介入肿瘤学市场展望：过去（2019-2023年）与预测（2024-2031年）

第8章 东亚介入肿瘤学市场展望：过去（2019-2023年）与预测（2024-2031年）

第9章 南亚和大洋洲介入肿瘤学市场展望：过去（2019-2023年）和预测（2024-2031年）

第10章 拉丁美洲介入肿瘤学市场展望：过去（2019-2023年）与预测（2024-2031年）

第11章 中东与非洲介入肿瘤学市场展望：过去（2019-2023年）与预测（2024-2031年）

第12章 竞争态势

  • 2023年市占率分析
  • 市场结构
    • 依市场划分的竞争强度图
    • 竞争仪表板
  • 公司简介（详细资料 - 概述、财务状况、策略、近期发展）
    • Profound Medical
    • Medtronic Plc.
    • Hologic, Inc.
    • Boston Scientific Corporation
    • AngioDynamics
    • Terumo Corporation
    • Teleflex Incorporated
    • Alpinion Medical Systems Co. Ltd.
    • Siemens Healthineers
    • Merit Medical

第13章 附录

  • 调查方法
  • 调查假设
  • 首字母缩写词和缩写词
简介目录
Product Code: PMRREP34749

Persistence Market Research has recently published an extensive report on the global Interventional Oncology Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • Interventional Oncology Market Size (2024E): USD 2.1 Bn
  • Projected Market Value (2031F): USD 3.5 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 8.1%

Interventional Oncology Market - Report Scope:

The Interventional Oncology Market involves the application of minimally invasive procedures for cancer treatment, utilizing advanced technologies such as radiofrequency ablation, cryoablation, and microwave ablation. These techniques aim to reduce patient discomfort and recovery time while providing effective tumor targeting, driving demand for such treatments in hospitals, clinics, and homecare settings. The market growth is propelled by the rising prevalence of cancer, technological advancements in imaging, and a growing focus on patient-centric care. Innovations in sedation, pain management, and monitoring technologies further support market expansion, enhancing the overall procedural experience for patients.

Market Growth Drivers:

The global Interventional Oncology Market is primarily driven by the increasing prevalence of cancer and the growing adoption of minimally invasive treatments. Technological advancements in imaging and interventional devices are enhancing procedural accuracy and safety, contributing to better patient outcomes. Furthermore, the demand for targeted cancer therapies is on the rise as patients and healthcare providers increasingly prefer less invasive treatment options that offer quicker recovery times and reduced complications. Innovations in device technology and the growing emphasis on personalized cancer treatments are also fueling market growth, with investments in research and development advancing new techniques.

Market Restraints:

Despite its promising growth, the Interventional Oncology Market faces challenges such as limited accessibility to advanced treatments in low and middle-income countries. Inadequate healthcare infrastructure, a shortage of specialized professionals, and the high cost of state-of-the-art equipment restrict the adoption of these treatments in resource-constrained regions. Moreover, disparities in access to the latest interventional oncology technologies hinder patient outcomes, particularly in developing nations. Addressing these barriers will require focused efforts to improve healthcare infrastructure, training, and the availability of advanced cancer care worldwide.

Market Opportunities:

Significant opportunities exist within the Interventional Oncology Market, especially with the increasing demand for personalized and home-based healthcare solutions. Innovations in imaging tools, including MRI and CT scans, are enhancing the precision of tumor targeting, creating opportunities for further market growth. The expansion of e-commerce platforms and direct-to-consumer sales channels is also providing easier access to these technologies, particularly in remote areas. Additionally, collaborations with healthcare providers and wellness centers are promoting the adoption of interventional oncology devices, further driving market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Interventional Oncology Market globally?
  • Which product types, such as ablation devices, are expanding the most in the market?
  • How are advancements in imaging technologies and patient monitoring influencing the competitive landscape of the Interventional Oncology Market?
  • Who are the key players in the Interventional Oncology Market, and what strategies are they using to maintain their competitive edge?
  • What are the emerging trends and future prospects in the global Interventional Oncology Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Interventional Oncology Market are focusing on innovation, strategic collaborations, and research and development to maintain a competitive edge. Companies are investing in the development of advanced ablation devices and exploring new product formats to meet evolving patient needs. Collaborations with hospitals, clinics, and healthcare providers help facilitate the adoption of these technologies, while marketing strategies emphasize consumer education and high-quality products. These efforts, combined with a focus on improving patient outcomes and minimizing recovery times, are contributing to sustained growth in the Interventional Oncology Market.

Key Market Players

  • Profound Medical
  • Medtronic Plc.
  • Hologic, Inc.
  • Boston Scientific Corporation
  • AngioDynamics
  • Terumo Corporation
  • Teleflex Incorporated
  • Alpinion Medical Systems Co. Ltd.
  • Siemens Healthineers
  • Merit Medical

Interventional Oncology Industry Segmentation

By Product

  • Radiation Therapy Devices
  • Ablation Devices
  • Embolization Devices

By Cancer Type

  • Lung Cancer
  • Liver Cancer
  • Kidney Cancer
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centre

By Region

  • North America
  • Europe
  • Asia Pacific
  • The Middle East and Africa
  • Latin America

Table of Contents

1. Executive Summary

  • 1.1. Global Interventional Oncology Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Product Adoption Analysis
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Global Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
    • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
  • 4.3. Global Interventional Oncology Market Outlook: Product
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2023
    • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
      • 4.3.3.1. Radiation Therapy Devices
      • 4.3.3.2. Ablation Devices
        • 4.3.3.2.1. Microwave ablation
        • 4.3.3.2.2. Radiofrequency ablation
        • 4.3.3.2.3. Cryoablation
        • 4.3.3.2.4. Others
      • 4.3.3.3. Embolization Devices
        • 4.3.3.3.1. Microcatheters
        • 4.3.3.3.2. Guidewires
  • 4.4. Market Attractiveness Analysis: Product
  • 4.5. Global Interventional Oncology Market Outlook: Cancer Type
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By Cancer Type, 2019-2023
    • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
      • 4.5.3.1. Lung Cancer
      • 4.5.3.2. Liver Cancer
      • 4.5.3.3. Kidney Cancer
      • 4.5.3.4. Others
  • 4.6. Market Attractiveness Analysis: Cancer Type
  • 4.7. Global Interventional Oncology Market Outlook: End User
    • 4.7.1. Introduction / Key Findings
    • 4.7.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
    • 4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
      • 4.7.3.1. Hospitals
      • 4.7.3.2. Specialty Clinics
      • 4.7.3.3. Ambulatory Surgical Center
      • 4.7.3.4. Others
  • 4.8. Market Attractiveness Analysis: End User

5. Global Interventional Oncology Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
  • 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024-2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 6.2.1. By Country
    • 6.2.2. By Product
    • 6.2.3. By Cancer Type
    • 6.2.4. By Route of Administration
    • 6.2.5. By End User
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 6.4.1. Radiation Therapy Devices
    • 6.4.2. Ablation Devices
      • 6.4.2.1. Microwave ablation
      • 6.4.2.2. Radiofrequency ablation
      • 6.4.2.3. Cryoablation
      • 6.4.2.4. Others
    • 6.4.3. Embolization Devices
      • 6.4.3.1. Microcatheters
      • 6.4.3.2. Guidewires
  • 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
    • 6.5.1. Lung Cancer
    • 6.5.2. Liver Cancer
    • 6.5.3. Kidney Cancer
    • 6.5.4. Others
  • 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 6.6.1. Hospitals
    • 6.6.2. Specialty Clinics
    • 6.6.3. Ambulatory Surgical Center
    • 6.6.4. Others
  • 6.7. Market Attractiveness Analysis

7. Europe Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Cancer Type
    • 7.2.4. By Route of Administration
    • 7.2.5. By End User
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 7.4.1. Radiation Therapy Devices
    • 7.4.2. Ablation Devices
      • 7.4.2.1. Microwave ablation
      • 7.4.2.2. Radiofrequency ablation
      • 7.4.2.3. Cryoablation
      • 7.4.2.4. Others
    • 7.4.3. Embolization Devices
      • 7.4.3.1. Microcatheters
      • 7.4.3.2. Guidewires
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
    • 7.5.1. Lung Cancer
    • 7.5.2. Liver Cancer
    • 7.5.3. Kidney Cancer
    • 7.5.4. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 7.6.1. Hospitals
    • 7.6.2. Specialty Clinics
    • 7.6.3. Ambulatory Surgical Center
    • 7.6.4. Others
  • 7.7. Market Attractiveness Analysis

8. East Asia Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Cancer Type
    • 8.2.4. By Route of Administration
    • 8.2.5. By End User
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 8.4.1. Radiation Therapy Devices
    • 8.4.2. Ablation Devices
      • 8.4.2.1. Microwave ablation
      • 8.4.2.2. Radiofrequency ablation
      • 8.4.2.3. Cryoablation
      • 8.4.2.4. Others
    • 8.4.3. Embolization Devices
      • 8.4.3.1. Microcatheters
      • 8.4.3.2. Guidewires
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
    • 8.5.1. Lung Cancer
    • 8.5.2. Liver Cancer
    • 8.5.3. Kidney Cancer
    • 8.5.4. Others
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 8.6.1. Hospitals
    • 8.6.2. Specialty Clinics
    • 8.6.3. Ambulatory Surgical Center
    • 8.6.4. Others
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Cancer Type
    • 9.2.4. By Route of Administration
    • 9.2.5. By End User
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 9.4.1. Radiation Therapy Devices
    • 9.4.2. Ablation Devices
      • 9.4.2.1. Microwave ablation
      • 9.4.2.2. Radiofrequency ablation
      • 9.4.2.3. Cryoablation
      • 9.4.2.4. Others
    • 9.4.3. Embolization Devices
      • 9.4.3.1. Microcatheters
      • 9.4.3.2. Guidewires
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
    • 9.5.1. Lung Cancer
    • 9.5.2. Liver Cancer
    • 9.5.3. Kidney Cancer
    • 9.5.4. Others
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 9.6.1. Hospitals
    • 9.6.2. Specialty Clinics
    • 9.6.3. Ambulatory Surgical Center
    • 9.6.4. Others
  • 9.7. Market Attractiveness Analysis

10. Latin America Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Cancer Type
    • 10.2.4. By Route of Administration
    • 10.2.5. By End User
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 10.4.1. Radiation Therapy Devices
    • 10.4.2. Ablation Devices
      • 10.4.2.1. Microwave ablation
      • 10.4.2.2. Radiofrequency ablation
      • 10.4.2.3. Cryoablation
      • 10.4.2.4. Others
    • 10.4.3. Embolization Devices
      • 10.4.3.1. Microcatheters
      • 10.4.3.2. Guidewires
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
    • 10.5.1. Lung Cancer
    • 10.5.2. Liver Cancer
    • 10.5.3. Kidney Cancer
    • 10.5.4. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 10.6.1. Hospitals
    • 10.6.2. Specialty Clinics
    • 10.6.3. Ambulatory Surgical Center
    • 10.6.4. Others
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Cancer Type
    • 11.2.4. By Route of Administration
    • 11.2.5. By End User
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 11.4.1. Radiation Therapy Devices
    • 11.4.2. Ablation Devices
      • 11.4.2.1. Microwave ablation
      • 11.4.2.2. Radiofrequency ablation
      • 11.4.2.3. Cryoablation
      • 11.4.2.4. Others
    • 11.4.3. Embolization Devices
      • 11.4.3.1. Microcatheters
      • 11.4.3.2. Guidewires
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
    • 11.5.1. Lung Cancer
    • 11.5.2. Liver Cancer
    • 11.5.3. Kidney Cancer
    • 11.5.4. Others
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 11.6.1. Hospitals
    • 11.6.2. Specialty Clinics
    • 11.6.3. Ambulatory Surgical Center
    • 11.6.4. Others
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Profound Medical
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Medtronic Plc.
    • 12.3.3. Hologic, Inc.
    • 12.3.4. Boston Scientific Corporation
    • 12.3.5. AngioDynamics
    • 12.3.6. Terumo Corporation
    • 12.3.7. Teleflex Incorporated
    • 12.3.8. Alpinion Medical Systems Co. Ltd.
    • 12.3.9. Siemens Healthineers
    • 12.3.10. Merit Medical

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations